Treatment of neuropsychiatric disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 21, 1995
Issued Date -
N/A
app pub date -
Feb 23, 1990
filing date -
Jan 26, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders. Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully